Table 4

Stage 1 and 2 validation of brief FHQ using pooled data

ConditionQuestion number(s)Sensitivity, % (95% CI) [n]Specificity, % (95% CI) [n]Positive likelihood ratioNegative likelihood ratioPositive predictive value, %False-positive rate, %
Diabetes398 (95 to 99%)
[208/213]
94 (92 to 95)
[854/913]
15.11a0.03a77.90.6
Ischaemic heart disease293 (87 to 96)
[141/152]
81 (79 to 84)
[804/990]
4.94b0.09a43.11.3
Breast cancer6 or 881 (67 to 91)
[39/48]
83 (80 to 85)
[598/723]
4.700.2223.81.5
Colorectal cancer10 or 1196 (80 to 99)
[24/25]
88 (86 to 89)
[976/1114]
7.75b0.05a14.90.1
  • a Strong clinical significance.

  • b Modest clinical significance.